Seeing Is Believing
Currently out of the existing stock ratings of Greg Chodaczek, 1 are a BUY (100%).
Analyst Greg Chodaczek, carries an average stock price target met ratio of 100% that have a potential upside of 97.45% achieved within 2327 days. Previously, Greg Chodaczek worked at B. RILEY.
Greg Chodaczek’s has documented 1 price targets and ratings displayed on 3 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ADMP, Adamis Pharma at 20-Dec-2016.
Analyst best performing recommendations are on ADMP (ADAMIS PHARMA).
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 22-Mar-2022
4 years 4 months 8 days ago
(19-May-2022)
4/4 (100%)
$-43.45 (-97.75%)
1702
Hold Since 16-Nov-2020
$1.5
5 years 10 months 11 days ago
(16-Nov-2020)
2/2 (100%)
$-38.7 (-96.27%)
1340
Hold Since 26-Nov-2019
6 years 10 months 1 days ago
(26-Nov-2019)
1/1 (100%)
$-364 (-98.11%)
2030
$5
$4.51 (920.41%)
9 years 9 months 7 days ago
(20-Dec-2016)
1/1 (100%)
$-191 (-97.45%)
2327